Sanadelaslam S. A. El‐Hddad

Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme

Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr et al. · Bioorganic Chemistry · 2020 · 96 citations

Molecular Docking, Medicinal Chemistry, Engineering +10

Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5‐[(4‐chloro/2,4‐dichloro)benzylidene]thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors

Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr et al. · Archiv der Pharmazie · 2020 · 56 citations

Design, synthesis, molecular docking, and anticancer evaluations of 1‐benzylquinazoline‐2,4(1<i>H</i>,3<i>H</i>)‐dione bearing different moieties as VEGFR‐2 inhibitors

Khaled El‐Adl, Abdel‐Ghany A. El‐Helby, Helmy Sakr et al. · Archiv der Pharmazie · 2020 · 54 citations

Design, Molecular Docking, Synthesis, Anticancer and Anti-Hyperglycemic Assessments of Thiazolidine-2,4-diones Bearing Sulfonylthiourea Moieties as Potent VEGFR-2 Inhibitors and PPARγ Agonists

Mohamed A. Abdelgawad, Khaled El‐Adl, Sanadelaslam S. A. El‐Hddad et al. · Pharmaceuticals · 2022 · 48 citations · Full text

Design, synthesis, docking, ADMET profile, and anticancer evaluations of novel thiazolidine‐2,4‐dione derivatives as VEGFR‐2 inhibitors

Khaled El‐Adl, Helmy Sakr, Sanadelaslam S. A. El‐Hddad et al. · Archiv der Pharmazie · 2021 · 44 citations